R 2579 R 2579 (Diltiazem CD 300 mg)
Pill imprint R 2579 R 2579 has been identified as Diltiazem hydrochloride extended-release (CD) 300 mg.
Diltiazem is used in the treatment of atrial fibrillation; high blood pressure; supraventricular tachycardia; atrial flutter; raynaud's syndrome (and more), and belongs to the drug classes calcium channel blocking agents, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Diltiazem 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- R 2579 R 2579
- 300 mg
- Green / Gray
- Prescription only
- Drug Class:
- Calcium channel blocking agents
Group IV antiarrhythmics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- National Drug Code (NDC):
- Inactive Ingredients:
- methacrylic acid - methyl methacrylate copolymer (1:1)
methacrylic acid - methyl methacrylate copolymer (1:2)
sodium lauryl sulfate
D&C Yellow No. 10
FD&C Green No. 3
|NDC Code||Manufacturer / Repackager|
|62584-0977||Amerisource Health Services|
|63739-0286||McKesson Packaging Services|
|54868-4992||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
More about diltiazem
- Diltiazem 12-hour sustained-release capsules
- Diltiazem 24-hour extended-release beads capsules
- Diltiazem 24-hour extended-release beads tablets
- Diltiazem 24-hour sustained-release beads capsules
- More (4) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.